XBiotech Inc. (XBIT) Financials
XBIT Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-12-31 | 227.2 million | 8.4 million |
2023-09-30 | 229.6 million | 6.9 million |
2023-06-30 | 235.1 million | 6.1 million |
2023-03-31 | 242.1 million | 5.2 million |
XBIT Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-12-31 | -3.5 million | 688000 |
2023-09-30 | -1.5 million | 955000 |
2023-06-30 | -9.2 million | 914000 |
2023-03-31 | -4.8 million | 705000 |
XBIT Net Income
Graph available only for supporters. Become a supporter to see it.
Date | Net Income |
---|---|
2023-12-31 | -4.6 million |
2023-09-30 | -7.4 million |
2023-06-30 | -8.7 million |
2023-03-31 | -3.8 million |
XBIT Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-12-31 | 200.0 million | - | - |
2023-09-30 | 202.2 million | - | - |
2023-06-30 | 204.8 million | - | - |
2023-03-31 | 212.7 million | - | - |
XBIT Shares Outstanding
XBIT Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-12-31 | 115000 | 7.8 million | 783000 | 434000 |
2023-09-30 | 33000 | 7.5 million | 973000 | - |
2023-06-30 | 208000 | 11.3 million | 2.0 million | - |
2023-03-31 | 6000 | 6.2 million | 915000 | - |
XBIT Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-12-31 | - | 434000 |
2023-09-30 | - | 432000 |
2023-06-30 | - | 435000 |
2023-03-31 | - | 443000 |
XBIT
Price: $8.67
52 week price:
Payout Ratio Range:
Earnings Per Share: -0.81 USD
P/E Ratio: -7.22
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Volume: 35800
Ebitda: -47.9 millionMarket Capitalization: 250.0 million